Table 3 EOS end of study, EOF end of follow-up

Informed consent

X

–

–

–

–

Inclusion/exclusion criteria

X

–

–

–

–

Demographic data and medical history

X

–

–

–

–

Concomitant medication

X

–

–

–

–

Vital signs*

X

X

–

–

–

Anthropometric data^{^}

X

–

–

–

–

Basal laboratory

X

–

–

–

–

PCR swab

–

X

X

–

–

Assessment of adverse events

–

X

X

X

–

Final objective evaluation

–

X

X

X

X

Randomization

X

–

–

–

–

Adherence to treatment

X

X

–

–

–